References
Brose, M. S. et al. Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT trial. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2016.71.6472 (2017)
Rights and permissions
About this article
Cite this article
Hutchinson, L. Lenvatinib SELECTs survival benefit. Nat Rev Clin Oncol 14, 458–459 (2017). https://doi.org/10.1038/nrclinonc.2017.103
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2017.103
- Springer Nature Limited